Nexeon MedSystems is committed to improving lives through the development of breakthrough therapies for people with cardiovascular disease. With proven medical device research and development talent, a strong intellectual property portfolio and the leadership of a veteran interventional cardiologist, Nexeon has created an innovative pipeline of products for unmet clinical needs.

Nexeon was founded in 2004 by Mark C. Bates, M.D., a thought leader in interventional cardiology and a medical device inventor with more than 25 issued and pending patents. Dr. Bates formed Nexeon with the goal of changing how innovative ideas in the medical device industry move from concept to reality. Nexeon's team of scientists, engineers, clinicians and business leaders share this vision.

The company's employees have strong track records of successfully developing and commercializing new technologies. Working in conjunction with physicians, scientific advisors and business experts, the team has advanced the founding medical device concepts of Dr. Bates into a diversified portfolio of products that will benefit patients with cardiovascular disease and many other medical conditions.

Key Facts

Founded: 2004
Business: Development of specialized medical technology primarily focused on the minimally invasive treatment of cardiovascular disease
Location: Headquarters in Charleston, W. Va; R&D center in Carlsbad, Calif.
Employees: 25
Ownership: Privately held
Investors: Majority stake held by private equity and individual investors from the West Virginia business sector; corporate investments from SurModics, Inc., and Guidant Corporation (now Abbott Laboratories and Boston Scientific)
Lead technologies: Prohealing PROTEX™ Coronary Stent System; peripheral stent family; nanotechnology-based medical devices
Corporate partners: SurModics, Inc. and Unidym, Inc. in the areas of coronary stenting and nanotechnology, respectively
Revenue: Company’s products are in development and/or clinical trials
Web address: www.nexeonmedsystems.com

CAUTION – Investigational device. Limited by Federal (U.S.) law to investigational use.